Xueqin Gao

Dr. Xueqin Gao

Linda and Mitch Hart Center for Regenerative and Personalized Medicine, Steadman Philippon Research Institute, 181 W Meadow Dr, Suite 1000, Vail, CO, USA
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Stem Cells
Verified
Journal Article
Closed access
PDF file
CCChien-Wen Chen
Chien-Wen Chen
MOMasaho Okada
Masaho Okada
JPJonathan D. Proto
Jonathan D. Proto
XGXueqin Gao
Xueqin Gao
NSNaosumi Sekiya
Naosumi Sekiya
JHJohnny Huard
Johnny Huard

1 September 2018 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
ZDZ.H. Deng
Z.H. Deng
YLY.S. Li
Y.S. Li
XGXueqin Gao
Xueqin Gao
GLGuang-Hua Lei
Guang-Hua Lei
JHJohnny Huard
Johnny Huard

1 August 2014 in Biomaterials
Verified
Journal Article
Closed access
XGXueqin Gao
Xueqin Gao
AUArvydas Usas
Arvydas Usas
YTYing Tang
Ying Tang
ALAiping Lu
Aiping Lu
JTJian Tan
Jian Tan
JHJohnny Huard
Johnny Huard

19 May 2014 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
XGXueqin Gao
Xueqin Gao
AUArvydas Usas
Arvydas Usas
JPJonathan D. Proto
Jonathan D. Proto
ALAiping Lu
Aiping Lu
JCJames H. Cummins
James H. Cummins
JHJohnny Huard
Johnny Huard
Murine muscle‐derived stem cells (MDSCs) have been shown capable of regenerating bone in a critical size calvarial defect model when transduced with BMP 2 or 4; however, the contribution of the donor cells and their interactions with the host cells during the bone healing process have not been fully elucidated. To address this question, C57/BL/6J mice were divided into MDSC/BMP4/GFP, MDSC/GFP, and scaffold groups. After transplanting MDSCs into the critical‐size calvarial defects created in normal mice, we found that mice transplanted with BMP4GFP‐transduced MDSCs healed the bone defect in 4 wk, while the control groups (MDSC‐GFP and scaffold) demonstrated no bone healing. The newly formed trabecular bone displayed similar biomechanical properties as the native bone, and the donor cells directly participated in endochondral bone formation via their differentiation into chondrocytes, osteoblasts, and osteocytes via the BMP4‐pSMAD5 and COX‐2‐PGE2 signaling pathways. In contrast to the scaffold group, the MDSC groups attracted more inflammatory cells initially and incurred faster inflammation resolution, enhanced angiogenesis, and suppressed initial immune responses in the host mice. MDSCs were shown to attract macrophages via the secretion of monocyte chemotactic protein 1 and promote endothelial cell proliferation by secreting multiple growth factors. Our findings indicated that BMP4GFP‐transduced MDSCs not only regenerated bone by direct differentiation, but also positively influenced the host cells to coordinate and promote bone tissue repair through paracrine effects.—Gao, X., Usas, A., Proto, J. D., Lu, A., Cummins, J. H., Proctor, A., Chen, C.‐W., Huard, J. Role of donor and host cells in muscle‐derived stem cell‐mediated bone repair: differentiation vs. paracrine effects. FASEB J. 28, 3792–3809 (2014). www.fasebj.org

1 May 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
ZDZhenhan Deng
Zhenhan Deng
XGXueqin Gao
Xueqin Gao
XSXuying Sun
Xuying Sun
SASarah Amra
Sarah Amra
ALAiping Lu
Aiping Lu
JHJohnny Huard
Johnny Huard
This study investigated articular cartilage (AC) homeostasis and different signaling pathways involved in the superior cartilage regeneration of Murphy Roths large (MRL/MpJ) mice previously reported. We collected uninjured and destabilized medial meniscus (DMM)‐injured knees from 8‐wk‐old C57BL/6J and MRL/MpJ mice. We used micro‐computed tomography (microCT), histology, and immunohistochemistry to evaluate AC homeostasis and repair. We used the ear punch model to investigate the role of angiogenesis and inflammation in the superior healing of MRL/MpJ mice. We found fewer β‐catenin and more pSMAD5 positive cells in the uninjured AC of MRL/MpJ mice than that from C57BL/6J mice. MRL/MpJ mice exhibited better AC repair in DMM‐induced OA, as indicated by microCT results, Alcian blue, and Safranin O staining. Mechanistically, fewer β‐catenin, pSMAD2‐, pSMAD3‐, a disintegrin and metalloproteinase with thrombospondin motifs 4–, matrix metalloproteinase (MMP) 9–, and MMP13‐positive cells and more proliferating cell nuclear antigen—and pSMAD5‐positive cells were found in the DMM‐injured AC in MRL/MpJ mice than in normal mice. The accelerated ear wound healing of MRL/MpJ mice correlated with enhanced angiogenesis and macrophage polarization toward the M2a phenotype through elevated IL‐10 and IL‐4 expressing cells. Collectively, our study revealed that down‐regulation of pSMAD2/3, β‐catenin, and MMPs and up‐regulation of pSMAD5 and M2a macrophage polarization contribute to the enhanced cartilage repair observed in MRL/MpJ mice.—Deng, Z., Gao, X., Sun, X., Amra, S., Lu, A., Cui, Y., Eltzschig, H. K., Lei, G., Huard, J. Characterization of articular cartilage homeostasis and the mechanism of superior cartilage regeneration of MRL/MpJ mice. FASEB J. 33, 8809–8821 (2019). www.fasebj.org

6 February 2020 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
HUHajime Utsunomiya
Hajime Utsunomiya
XGXueqin Gao
Xueqin Gao
ZDZhenhan Deng
Zhenhan Deng
HCHaizi Cheng
Haizi Cheng
GNGilberto Nakama
Gilberto Nakama
JHJohnny Huard
Johnny Huard
Microfracture or bone marrow stimulation (BMS) is often the first choice for clinical treatment of cartilage injuries; however, fibrocartilage, not pure hyaline cartilage, has been reported because of the development of fibrosis in the repair tissue. Transforming growth factor β1 (TGF-β1), which can promote fibrosis, can be inhibited by losartan and potentially be used to reduce fibrocartilage. Blocking TGF-β1 would improve cartilage healing in a rabbit knee BMS model via decreasing the amount of fibrocartilage and increasing hyaline-like cartilage formation. Controlled laboratory study. An osteochondral defect was made in the patellar groove of 48 New Zealand White rabbits. The rabbits were divided into 3 groups: a defect group (defect only), a BMS group (osteochondral defect + BMS), and a BMS + losartan group (osteochondral defect + BMS + losartan). For the rabbits in the BMS + losartan group, losartan was administrated orally from the day after surgery through the day of euthanasia. Rabbits were sacrificed 6 or 12 weeks postoperatively. Macroscopic appearance, microcomputed tomography, histological assessment, and TGF-β1 signaling pathway were evaluated at 6 and 12 weeks postoperatively. The macroscopic assessment of the repair revealed that the BMS + losartan group was superior to the other groups tested. Microcomputed tomography showed superior healing of the bony defect in the BMS + losartan group in comparison with the other groups. Histologically, fibrosis in the repair tissue of the BMS + losartan group was significantly reduced when compared with the other groups. Results obtained with the modified O’Driscoll International Cartilage Repair Society grading system yielded significantly superior scores in the BMS + losartan group as compared with both the defect group and the BMS group (F value: 15.8, P < .001, P = .012, respectively). TGF-β1 signaling and TGF-β-activated kinase 1 of the BMS + losartan group were significantly suppressed in the synovial tissues. By blocking TGF-β1 with losartan, the repair cartilage tissue after BMS was superior to the other groups and consisted primarily of hyaline cartilage. These results should be easily translated to the clinic because losartan is a Food and Drug Administration–approved drug and it can be combined with the BMS technique for optimal repair of chondral defects. Biologically regulated marrow stimulation by blocking TGF-β1 (oral intake of losartan) provides superior repair via decreasing fibrocartilage formation and resulting in hyaline-like cartilage as compared with outcomes from BMS only.